(1) An applicant for a clinical pharmacist practitioner registration shall:
(a) submit an application on a form prescribed by the board;
(b) pay a registration fee as prescribed by the board;
(c) hold an active, unrestricted Montana pharmacist license;
(d) have completed the years of clinical practice experience that meet the requirements for Board of Pharmacy Specialties (BPS) certification or other equivalent national certification, and hold one of the following active certifications:
(i) BPS certification; or
(ii) nationally recognized certification equivalent to BPS certification standards in an area of practice as approved by the board and the Board of Medical Examiners (BME).
(e) submit a signed collaborative practice agreement to the board that includes a description of the type of supervision the collaborating practitioner will exercise over the clinical pharmacist practitioner;
(f) following approval of the board, submit the application and collaborative practice agreement to the BME for approval; and
(g) appear before the board and/or BME if requested.
(2) Within ten days of discontinuing work under an approved collaborative drug therapy agreement, the pharmacist shall notify the board and the clinical pharmacist practitioner's registration shall be inactive, until such time as a new application is approved.